Atlas Trials

Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing

Clinical trial NCT03433833 · WITHDRAWN

Trial details

NCT number
NCT03433833
Sponsor
University of Illinois at Chicago
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Polycythemia; FamilialErythrocytosis; FamilialVHL Gene MutationHIF-2alpha ErythrocytosisPHD2 ErythrocytosisChuvash Erythrocytosis
Start date
2019-11-10
Primary completion
2024-04-16
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.